Orthofix Medical (OFIX) Share-based Compensation (2016 - 2026)
Orthofix Medical has reported Share-based Compensation over the past 16 years, most recently at $6.5 million for Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 0.99% year-over-year to $6.5 million, compared with a TTM value of $28.8 million through Mar 2026, down 4.55%, and an annual FY2025 reading of $28.7 million, down 11.61% over the prior year.
- Share-based Compensation came in at $6.5 million for Q1 2026, down from $7.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $13.2 million in Q2 2023 to a low of $3.2 million in Q4 2023.
- Median Share-based Compensation over the past 5 years was $6.5 million (2026), compared with a mean of $7.2 million.
- The largest YoY upside for Share-based Compensation was 200.55% in 2023 against a maximum downside of 35.66% in 2023.
- Over 5 years, Share-based Compensation stood at $4.9 million in 2022, then plummeted by 35.66% to $3.2 million in 2023, then skyrocketed by 126.24% to $7.2 million in 2024, then increased by 0.68% to $7.2 million in 2025, then decreased by 9.44% to $6.5 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Share-based Compensation are $6.5 million (Q1 2026), $7.2 million (Q4 2025), and $7.2 million (Q3 2025).